Aurora Cannabis Urges Shareholders to Reject Revised Hostile Bid From Curaleaf
The board of directors at Aurora Cannabis Inc. (NASDAQ:ACB) has unanimously recommended that shareholders reject a revised hostile takeover offer from Curaleaf Holdings, Inc. (TSX:CURA). The target company advised investors to take no action on the updated proposal while an independent special committee actively reviews alternative options. In recent trading, Aurora Cannabis Inc. shares fell 2.10% to $4.20 USD on NASDAQ and 2.29% to 5.97 CAD on the TSX, while Curaleaf Holdings, Inc. stock dropped 2.63% to 12.21 CAD.
Company leadership stated that the revised offer continues to significantly undervalue Aurora Cannabis Inc. and fails to resolve previously raised board concerns. Directors highlighted that the business is debt-free with a strong cash position. The board argued that the cash component of the offer would effectively be funded using Aurora's own balance sheet, while leaving Aurora investors exposed to potential declines in Curaleaf's stock valuation.
Aurora Cannabis Inc.'s special committee is currently exploring strategic alternatives to maximize shareholder value, including potential transactions with third parties or continuing as a stand-alone business. The committee has signed confidentiality and standstill agreements with several interested parties and is conducting ongoing discussions. Curaleaf Holdings, Inc.'s takeover offer remains open until December 4, 2026, and the board plans to provide further updates as its strategic review progresses.
Key points
- Aurora Cannabis Inc. (NASDAQ:ACB) unanimously recommended shareholders reject Curaleaf Holdings, Inc.'s revised hostile takeover offer.
- The board stated the bid undervalues the company and uses Aurora's existing cash balance to fund the acquisition consideration.
- An independent special committee has signed confidentiality and standstill agreements with multiple potential transaction partners.
- Curaleaf Holdings, Inc.'s hostile tender offer is scheduled to remain open through December 4, 2026.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
Why is the Aurora Cannabis board rejecting Curaleaf's takeover bid?
Aurora's board states the revised offer undervalues the business, uses Aurora's own cash reserves to fund consideration, and exposes shareholders to Curaleaf share price risks.
When does Curaleaf's takeover offer for Aurora Cannabis expire?
The revised hostile tender offer from Curaleaf Holdings, Inc. is scheduled to remain open until December 4, 2026.
What actions is Aurora Cannabis taking while rejecting the offer?
An independent special committee is actively evaluating strategic alternatives, including discussions with potential suitors under confidentiality agreements.